Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone

Allergy and Asthma Proceedings

Volumn 32, Issue 2, 2011, Pages 127-136

  Katial, Rohit K ^a   Bernstein, David ^b   Prazma, Charlene M ^c   Lincourt, William R ^c   Stempel, David A ^c  

^a DEPARTMENT OF MEDICINE   (United States)

^b Bernstein Clinical Research Center   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DIVERTICULITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTICENTER STUDY; PARALLEL DESIGN; PEAK EXPIRATORY FLOW; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; THRUSH; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ALBUTEROL; ANDROSTADIENES; ASTHMA; CHILD; DRUG COMBINATIONS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953230473     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3426     Document Type: Article

References (23)

1. Fuhlbrigge A, Reed ML, Stempel DA, et al. The status of asthma control in the U.S. adult population. Allergy Asthma Proc 30:529-533, 2009.
2. Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 161:527-534, 2000. (Pubitemid 30129463)
3. Wallin A, Sue-Chu M, Bjermer L, et al. Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma. J Allergy Clin Immunol 112:72-78, 2003. (Pubitemid 36819810)
4. Lemanske RF, Jr., Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial. JAMA 285:2594-2603, 2001. (Pubitemid 32479899)
5. Condemi JJ, Goldstein S, Kalberg C, et al. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol 82:383-389, 1999. (Pubitemid 29203287)
6. Lundback B, Ronmark E, Lindberg A, et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 100:2-10, 2006. (Pubitemid 43033373)
7. Delea TE, Hagiwara M, Stempel DA, and Stanford RH. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma. Allergy Asthma Proc 31:211-218, 2010.
8. Hagiwara M, Delea TE, Stanford RH, and Stempel DA. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy. Allergy Asthma Proc 31:203-210, 2010.
9. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 162:2341-2351, 2000.
10. Hankinson JL, Odencrantz JR, and Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179-187, 1999. (Pubitemid 29036522)
11. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802, 1988.
12. Holt S, Masoli M, and Beasley R. Increasing compliance with inhaled corticosteroids through the use of combination therapy. J Allergy Clin Immunol 113:219-220, 2004. (Pubitemid 38210540)
13. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 344:219-224, 1994. (Pubitemid 24229008)
14. Kelsen SG, Church NL, Gillman SA, et al. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: A randomized clinical trial. J Asthma 36:703-715, 1999. (Pubitemid 30012845)
15. Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153:1481-1488, 1996. (Pubitemid 26141329)
16. Murray JJ, Church NL, Anderson WH, et al. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 20:173-180, 1999.
17. Bateman E, Nelson H, Bousquet J, et al. Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthmarelated events. Ann Intern Med 149:33-42, 2008.
18. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 170:836-844, 2004. (Pubitemid 39346477)
19. Masoli M, Weatherall M, Holt S, et al. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 60:730-734, 2005. (Pubitemid 41297891)
20. National Institutes of Health. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program Expert Panel Report 3, NIH Publication No. 07-4051, NIH NHLBI, Bethesda, MD. August 2007.
21. Kavuru M, Melamed J, Gross G, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 105:1108-1116, 2000. (Pubitemid 30418788)
22. Murray J, Rosenthal R, Somerville L, et al. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Ann Allergy Asthma Immunol 93:351-359, 2004. (Pubitemid 39382976)
23. Nelson HS, Wolfe JD, Gross G, et al. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment. Ann Allergy Asthma Immunol 91:263-269, 2003. (Pubitemid 37174159)